Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.

about

Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.

Item

http://www.wikidata.org/entity/Q47781187

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@en

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@nl

type

Item

label

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@en

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@nl

prefLabel

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@en

Pharmacokinetic Modeling of Vo ...... ve Dosing Regimen in Children.

@nl

P1476

Pharmacokinetic Modeling of Vo ...... ive Dosing Regimen in Children

@en

P2093

Andreas H Groll

http://www.w3.org/2001/XMLSchema#string

Carsten Müller

http://www.w3.org/2001/XMLSchema#string

Fedja Farowski

http://www.w3.org/2001/XMLSchema#string

Georg Hempel

http://www.w3.org/2001/XMLSchema#string

Judith Ullmann-Moskovits

http://www.w3.org/2001/XMLSchema#string

Peter Bader

http://www.w3.org/2001/XMLSchema#string

Silke Gastine

http://www.w3.org/2001/XMLSchema#string

Thomas Lehrnbecher

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.

Handling data below the limit of quantification in mixed effect models.

Voriconazole pharmacokinetics and pharmacodynamics in children.

Tips and traps analyzing pediatric PK data.

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.

P31

scholarly article

P356

10.1128/AAC.01194-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oliver A Cornely

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29038273

http://www.w3.org/2001/XMLSchema#string

P932

5740334

http://www.w3.org/2001/XMLSchema#string